1. Home
  2. NBY vs NVNO Comparison

NBY vs NVNO Comparison

Compare NBY & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBY
  • NVNO
  • Stock Information
  • Founded
  • NBY 2000
  • NVNO 1987
  • Country
  • NBY United States
  • NVNO United States
  • Employees
  • NBY N/A
  • NVNO N/A
  • Industry
  • NBY
  • NVNO Medical/Dental Instruments
  • Sector
  • NBY
  • NVNO Health Care
  • Exchange
  • NBY Nasdaq
  • NVNO Nasdaq
  • Market Cap
  • NBY 15.7M
  • NVNO 16.7M
  • IPO Year
  • NBY 2007
  • NVNO N/A
  • Fundamental
  • Price
  • NBY $1.20
  • NVNO N/A
  • Analyst Decision
  • NBY Strong Buy
  • NVNO
  • Analyst Count
  • NBY 1
  • NVNO 0
  • Target Price
  • NBY $0.85
  • NVNO N/A
  • AVG Volume (30 Days)
  • NBY 1.2M
  • NVNO 686.9K
  • Earning Date
  • NBY 11-06-2025
  • NVNO 10-30-2025
  • Dividend Yield
  • NBY N/A
  • NVNO N/A
  • EPS Growth
  • NBY N/A
  • NVNO N/A
  • EPS
  • NBY 0.41
  • NVNO N/A
  • Revenue
  • NBY $9,781,000.00
  • NVNO N/A
  • Revenue This Year
  • NBY $23.91
  • NVNO N/A
  • Revenue Next Year
  • NBY $32.05
  • NVNO N/A
  • P/E Ratio
  • NBY $3.52
  • NVNO N/A
  • Revenue Growth
  • NBY 113.47
  • NVNO N/A
  • 52 Week Low
  • NBY $0.46
  • NVNO $0.67
  • 52 Week High
  • NBY $4.44
  • NVNO $5.62
  • Technical
  • Relative Strength Index (RSI)
  • NBY 40.93
  • NVNO 31.91
  • Support Level
  • NBY $1.22
  • NVNO $0.85
  • Resistance Level
  • NBY $1.64
  • NVNO $1.02
  • Average True Range (ATR)
  • NBY 0.24
  • NVNO 0.06
  • MACD
  • NBY -0.16
  • NVNO 0.11
  • Stochastic Oscillator
  • NBY 0.38
  • NVNO 56.35

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Share on Social Networks: